Vivian Ohaimadike

PhD in Computational Biology, MIT AI for Life Sciences Fellow Led the team behind "MoleculeAI," a platform accelerating drug discovery timelines by 40% for Pfizer. Co-authored a landmark Nature paper on generative AI for cancer therapeutics. Partnered with Bill & Melinda Gates Foundation on AI-driven malaria vaccine research. Keynote speaker at Bio-IT African Conference 2024. Holds 15+ patents in AI-pharma applications.

7 Transformative Benefits of AI in Structural Engineering

From accelerating design timelines to creating safer buildings, AI in structural engineering delivers seven transformative benefits that are reshaping the industry.

All the latest

Subscribers Form